Evidence map›Paper›PMID 37429030›Full record

ArticleAnnals of internal medicine2023

Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study.

Anthony N Muiru, Jesse Y Hsu, Xiaoming Zhang, Lawrence J Appel, Jing Chen, Debbie L Cohen, Paul E Drawz, Barry I Freedman, Alan S Go, Jiang He and 14 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Authors' Reply: Concerns about Hospitalization on Cystatin C- and Creatinine-Based eGFR.Journal of the American Society of Nephrology : JASN · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Plasma proteomics of acute tubular injury.Nature communications · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 1 country.

Anthony N MuiruDivision of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).ORCID 0000-0003-2622-9658
Jesse Y HsuDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (J.Y.H., X.Z.).ORCID 0000-0002-1522-6534
Xiaoming ZhangDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (J.Y.H., X.Z.).ORCID 0000-0001-8669-4530
Lawrence J AppelDivision of General Internal Medicine, Johns Hopkins University, Baltimore, Maryland (L.J.A.).ORCID 0000-0002-0673-6823
Jing ChenSection of Nephrology & Hypertension, Tulane University School of Medicine, New Orleans, Louisiana (J.C.).
Debbie L CohenDivision of Nephrology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (D.L.C.).ORCID 0000-0002-1325-315X
Paul E DrawzDivision of Nephrology and Hypertension, University of Minnesota Medical School, Minneapolis, Minnesota (P.E.D.).ORCID 0000-0001-7301-9253
Barry I FreedmanSection on Nephrology, Wake Forest University, Winston-Salem, North Carolina (B.I.F.).ORCID 0000-0003-0275-5530
Alan S GoDivision of Research, Kaiser Permanente Northern California, Oakland, California (A.S.G.).ORCID 0000-0001-9109-0811
Jiang HeTulane University School of Public Health & Tropical Medicine, New Orleans, Louisiana (J.H.).ORCID 0000-0002-8286-9652
Edward J HorwitzCase Western Reserve University School of Medicine, Cleveland, Ohio (E.J.H.).
Raymond K HsuDivision of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).ORCID 0000-0002-7883-8984
James P LashDivision of Nephrology, University of Illinois Health, Chicago, Illinois (J.P.L., A.P., A.C.R.).ORCID 0000-0002-6580-4080
Kathleen D LiuDivision of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).ORCID 0000-0003-4891-8649
Ian E McCoyDivision of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California (A.N.M., R.K.H., K.D.L., I.E.M.).ORCID 0000-0001-6470-6959
Anna PorterDivision of Nephrology, University of Illinois Health, Chicago, Illinois (J.P.L., A.P., A.C.R.).
Panduranga RaoDivision of Nephrology, University of Michigan Health, Ann Arbor, Michigan (P.R.).ORCID 0000-0002-4699-5395
Ana C RicardoDivision of Nephrology, University of Illinois Health, Chicago, Illinois (J.P.L., A.P., A.C.R.).ORCID 0000-0001-8670-3644
Hernan Rincon-CholesDepartment of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio (H.R., J.T.).ORCID 0000-0003-3559-4374
James SondheimerDivision of Nephrology and Hypertension, Wayne State University School of Medicine, Detroit, Michigan (J.S.).ORCID 0000-0002-9538-9682
Jonathan TaliercioDepartment of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio (H.R., J.T.).ORCID 0000-0003-4320-7151
Mark UnruhUniversity of New Mexico Health Sciences, Albuquerque, New Mexico (M.U.).
Chi-Yuan HsuDivision of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California, and Division of Research, Kaiser Permanente Northern California, Oakland, California (C.H.).ORCID 0000-0001-8182-1238
CRIC Study Investigators
University of California, San Francisco · USUniversity of Illinois Urbana-Champaign · USUniversity of Pennsylvania · USCleveland Clinic · USKaiser Permanente · USTulane University · USJohns Hopkins University · USUniversity of Michigan · USUniversity of Minnesota Medical Center · USUniversity of New Mexico · USUniversity School · USWake Forest University · USWayne State University · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Scientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Katherine Teresa Mills · 2016 to 2026
$25.3M
Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI EDELMAN, MARTIN J. · 2002 to 2009
$20.2M
Study of the Care and Outcomes of REnal InsufficiencyU01DK060902 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GO, ALAN S · 2001 to 2025
$19.5M
Limited Competition for the Continuation of the Chronic Renal Insufficiency CohorU01DK061021 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI RAHMAN, MAHBOOB · 2001 to 2025
$17.3M
Prospective Renal Insufficiency Cohort Evaluation:PRICEU01DK060984 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI COHEN, DEBBIE L · 2001 to 2025
$17.0M
Prospective Cohort Study of Chronic Renal InsufficiencyU01DK061028 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, PANDURANGA S · 2001 to 2025
$16.9M
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1 TR000439NCRR NIH HHS M01 RR016500NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR029879NIDDK NIH HHS K23 DK119562NIDDK NIH HHS K24 DK092291NIDDK NIH HHS R01 DK114014NIDDK NIH HHS R01 DK119199NIDDK NIH HHS U01 DK060902NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK060980NIDDK NIH HHS U01 DK060984NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U01 DK061021NIDDK NIH HHS U01 DK061022NIDDK NIH HHS U01 DK061028NIDDK NIH HHS U24 DK060990NIGMS NIH HHS P20 GM109036
6 · The paper itself

Abstract

backgroundPrior studies associating acute kidney injury (AKI) with more rapid subsequent loss of kidney function had methodological limitations, including inadequate control for differences between patients who had AKI and those who did not.

objectiveTo determine whether AKI is independently associated with subsequent kidney function trajectory among patients with chronic kidney disease (CKD).

designMulticenter prospective cohort study.

settingUnited States.

participantsPatients with CKD ( MEASUREMENTS: Hospitalized AKI was defined by a 50% or greater increase in inpatient serum creatinine (SCr) level from nadir to peak. Kidney function trajectory was assessed using estimated glomerular filtration rate (eGFR) based on SCr level (eGFRcr) or cystatin C level (eGFRcys) measured at annual study visits.

resultsDuring a median follow-up of 3.9 years, 433 participants had at least 1 AKI episode. Most episodes (92%) had stage 1 or 2 severity. There were decreases in eGFRcr (-2.30 [95% CI, -3.70 to -0.86] mL/min/1.73 m LIMITATIONS: Few cases of severe AKI, no adjudication of AKI cause, and lack of information about nephrotoxic exposures after hospital discharge.

conclusionAfter pre-AKI eGFR, proteinuria, and other covariables were accounted for, the association between mild to moderate AKI and worsening subsequent kidney function in patients with CKD was small. PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

Indexed as

Acute Kidney InjuryRenal Insufficiency, ChronicCohort StudiesCreatinineCystatin CGlomerular Filtration RateHumansProspective StudiesRisk FactorsUnited StatesCreatinineCystatin C

Identifiers

PMID37429030
PMCPMC10829039
OpenAlexW4383748178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.